Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel R Weinberger

Showing results (1-10 of 514) with videos related to

Pageof 52
Sort By:
Vertex (Buenos Aires, Argentina)|December 13, 2002
[Fourth conference. Why atypical antipsychotics are really atypical?]Daniel R Weinberger
The American Journal of Psychiatry|March 9, 2019
Polygenic Risk Scores in Clinical Schizophrenia ResearchDaniel R Weinberger
Vertex (Buenos Aires, Argentina)|December 13, 2002
[First conference. Neurobiology of schizophrenia]Daniel R Weinberger
Clinical Therapeutics|October 4, 2005
Genetic mechanisms of psychosis: in vivo and postmortem genomicsDaniel R Weinberger
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 24, 2006
New directions in psychiatric therapeuticsDaniel R Weinberger
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 24, 2017
The neurodevelopmental origins of schizophrenia in the penumbra of genomic medicineDaniel R Weinberger
Schizophrenia Bulletin|October 18, 2017
Future of Days Past: Neurodevelopment and SchizophreniaDaniel R Weinberger
Vertex (Buenos Aires, Argentina)|December 13, 2002
[Second conference. From phenotype to genotype]Daniel R Weinberger
Vertex (Buenos Aires, Argentina)|December 13, 2002
[Third conference. Model of neural development in schizophrenia]Daniel R Weinberger
Nature Medicine|September 11, 2007
Schizophrenia drug says goodbye to dopamineDaniel R Weinberger
Pageof 52

Showing results (1-10 of 514) with videos related to

Sort By:
Pageof 52
Vertex (Buenos Aires, Argentina)|December 13, 2002
[Fourth conference. Why atypical antipsychotics are really atypical?]Daniel R Weinberger
The American Journal of Psychiatry|March 9, 2019
Polygenic Risk Scores in Clinical Schizophrenia ResearchDaniel R Weinberger
Vertex (Buenos Aires, Argentina)|December 13, 2002
[First conference. Neurobiology of schizophrenia]Daniel R Weinberger
Clinical Therapeutics|October 4, 2005
Genetic mechanisms of psychosis: in vivo and postmortem genomicsDaniel R Weinberger
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 24, 2006
New directions in psychiatric therapeuticsDaniel R Weinberger
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 24, 2017
The neurodevelopmental origins of schizophrenia in the penumbra of genomic medicineDaniel R Weinberger
Schizophrenia Bulletin|October 18, 2017
Future of Days Past: Neurodevelopment and SchizophreniaDaniel R Weinberger
Vertex (Buenos Aires, Argentina)|December 13, 2002
[Second conference. From phenotype to genotype]Daniel R Weinberger
Vertex (Buenos Aires, Argentina)|December 13, 2002
[Third conference. Model of neural development in schizophrenia]Daniel R Weinberger
Nature Medicine|September 11, 2007
Schizophrenia drug says goodbye to dopamineDaniel R Weinberger
Pageof 52